Yale study shows 25 percent of obese children are at high risk for developing diabetes

March 13, 2002

New Haven, Conn. - Twenty five percent of obese children and 21 percent of obese adolescents tested by Yale researchers were glucose intolerant and at high risk for developing diabetes, according to an article published Thursday in the New England Journal of Medicine.

Sonia Caprio, associate professor of endocrinology and pediatrics at Yale School of Medicine and senior author of the article, said the study was in response to the epidemic of childhood obesity in the United States, along with an accompanying increase in the prevalence of type 2 diabetes among children and adolescents.

Type One diabetes is usually first diagnosed in young children. Type 2, or, adult onset diabetes, often does not manifest itself until a person is middle aged or elderly.

"Most of these children are at high risk for type 2 diabetes," Caprio said. "And, if they develop diabetes before the age of 20, they face a lifetime of being at very high risk for complications from diabetes."

A glucose tolerance test evaluates the body's capacity to metabolize glucose, based upon the ability of the liver to absorb and store excess glucose as glycogen.

Caprio and her co-researchers looked at a multi-ethnic group of 167 severely obese children and adolescents. All underwent a two-hour oral glucose tolerance test during which glucose, insulin and C-peptide levels were measured.

The glucose intolerance was as prevalent among Caucasians as it was among African American and Hispanic children, who traditionally have higher rates of diabetes. The condition also was more prevalent among girls than boys.

Impaired glucose tolerance was detected in 25 percent of the children four to 10 years of age, and 21 percent of the adolescents 11 to 18 years of age. Silent type 2 diabetes, which means the persons are not aware they are diabetic, was identified in four of the adolescents. Two were Hispanic and two were African American. In addition, three of the children during the four-year course of the study progressed from glucose intolerance to diabetes.

Fourteen of the girls had polycystic ovary syndrome, which causes symptoms such as menstrual irregularities, hirsutism due to high androgen levels, and, over time, infertility, as well as cysts on their ovaries. The syndrome also is associated with darkening and thickening of the skin around the neck and under the arms.

Possible long term complications from diabetes include premature artherosclerosis, often affecting the legs and leading to ulcers of the feet; early coronary artery disease; kidney disorders; eye disorders, sometimes leading to blindness, and nerve problems.
Co-authors included Ranjana Sinha, M.D., Gene Fisch, Barbara Teague, R.N., William Tamborlane, M.D., Bruna Banyas, R.N., Karin Allen, R.N., Mary Savoye, Vera Rieger, M.D., Sara Taksali, Gina Barbetta, Robert Sherwin, M.D., and Sonia Caprio, M.D.

The study was funded by the National Institute of Child Health and Human Development of the National Institutes of Health and the National Center for Research Resources (NCRR). The NCRR awarded grants to Yale for two General Clinical Research Centers that host adult and child studies. NCRR funding provides NIH-supported investigators with access to specialized basic and clinical research facilities, technologies, instrumentation, biomaterials, animal models, genetic stocks, and more.

Yale University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.